S1-Leitlinie: Kaposi-Sarkom

Area of Science:

• Oncology
• Vascular Biology
• Epidemiology

Background:

• Kaposi sarcoma (KS) is a rare, malignant vascular neoplasm originating from lymphatic endothelial cells.
• It can affect the skin, mucous membranes, lymphatic system, and internal organs.
• Five epidemiological subtypes of KS exist, each with a variable clinical course and prognosis.

Purpose of the Study:

• To summarize current, practice-relevant recommendations for the diagnosis and therapy of Kaposi sarcoma.
• To provide an interdisciplinary guideline for clinicians managing KS patients.

Main Methods:

• The guideline synthesizes current clinical evidence and expert consensus.
• It addresses diagnostic and therapeutic strategies for the five distinct KS subtypes.
• Recommendations are based on a review of relevant literature and clinical experience.

Main Results:

• The guideline details diagnostic criteria for each KS subtype.
• It outlines current therapeutic options, including systemic and local treatments.
• Specific recommendations are provided for managing KS in different patient populations, including those with HIV/AIDS and immunosuppression.

Conclusions:

• This guideline offers a comprehensive overview of KS diagnosis and treatment.
• It aims to standardize care and improve outcomes for patients with Kaposi sarcoma.
• Further details and extensive recommendations are available in the full guideline version.